<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/38170/active-surveillance-for-favorable-risk-mrcc?channelName=kidneycancer&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Active Surveillance for Favorable Risk mRCC

Name: Active Surveillance for Favorable Risk mRCC
Uploaded: 2019-11-16T06:30:07
Duration: 10 min 22 s
Description: Michael R. Harrison, MD Associate Professor of Medicine Duke Cancer Institute discusses Active Surveillance for Favorable Risk mRCC at the 18th International Kidney Cancer Symposium 2019, Miami, FL.

0:10:22

Kidney Cancer

3 years 48 Views

Share Add to Report 0 0

Embed (Iframe):

<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/38170/active-surveillance-for-favorable-risk-mrcc?channelName=kidneycancer&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Embed (Object):

<div class="embed-responsive embed-responsive-16by9"><object width="640" height="360"><param name="movie" value="https://oncologytube.com/videoEmbed/38170/active-surveillance-for-favorable-risk-mrcc?channelName=kidneycancer&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit="></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="https://oncologytube.com/videoEmbed/38170/active-surveillance-for-favorable-risk-mrcc?channelName=kidneycancer&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" allowscriptaccess="always" allowfullscreen="true" width="640" height="360"></embed></object></div>

Link (HTML):

<a href="https://oncologytube.com/v/38170?channelName=kidneycancer"><img src="https://oncologytubecom.cdn.ypt.me/videos/_YPTuniqid_5dd007ef421254.92297053/_YPTuniqid_5dd007ef421254.92297053.jpg?cache=15739146111678829642">Active Surveillance for Favorable Risk mRCC</a>

Link (BBCode):

[url=https://oncologytube.com/v/38170?channelName=kidneycancer][img]https://oncologytubecom.cdn.ypt.me/videos/_YPTuniqid_5dd007ef421254.92297053/_YPTuniqid_5dd007ef421254.92297053.jpg?cache=15739146111678829642[/img]Active Surveillance for Favorable Risk mRCC[/url]

Sign in now!

Permanent Link

URL Friendly (SEO)

Current Time (SEO)

Category:

Kidney

Description:

Michael R. Harrison, MD Associate Professor of Medicine
Duke Cancer Institute discusses Active Surveillance for Favorable Risk mRCC at the 18th International Kidney Cancer Symposium 2019, Miami, FL.